‘Bloody interesting companies’ deliver for Woodford
Immunocore leads trio of positive updates from the Patient Capital Trust
Immunocore leads trio of positive updates from the Patient Capital Trust
|
|
But responsibility falls on DFM if these products go pear-shaped
|
|
Benjamin Disraeli was in power when the first investment trust launched
|
|
FTSE yield is high and capital gains meagre, says UK equity manager
|
|
‘Red October’ sell-off is likely to have made target stocks attractive
|
|
Asset-backed income upwards of 8% comes with risk
|
|
Asian Smaller Companies rebrands and promotes Hugh Young in raft of changes
|
|
Frontiers investment trust holds just a fifth of its portfolio in Europe
|
|
European Supervisory Authorities’ timeline is too ambitious
|
|
OECD crackdown prompts infrastructure fund’s shift to UK
|
|
Alibaba and Spotify among the investment trust’s successful picks
|
|
Fundraise deemed ‘decent result’ in light of challenging markets and competition from Terry Smith
|
|